Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity

Digestive Diseases and Sciences

Volumn 45, Issue 5, 2000, Pages 870-879

  Kiyozuka, Yasuhiko ^a   Asai, Akira ^a   Yamamoto, Daigo ^a   Senzaki, Hideto ^a   Yoshioka, Sadako ^a   Takahashi, Hakuo ^a   Hioki, Koshiro ^a   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell line; Differentiation; Esophageal cancer; Telomerase; Telomerase RNA; Telomere

Indexed keywords

CYTOKERATIN; RNA; TELOMERASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL POPULATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; GROWTH CURVE; HUMAN; HUMAN CELL; KARYOTYPE; MALE; MITOSIS INDEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELOMERE;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINS; MALE; MIDDLE AGED; RNA, MESSENGER; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034101788     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005504503975     Document Type: Article

References (44)

1. 1. Zakian VA: Telomeres: Beginning to understand the end. Science 270:1601-1607, 1995
2. 2. Blackburn EH: Structure and function of telomeres. Nature 350:569-573, 1991
3. 3. Harley CB, Villeponteau B: Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5:249-255, 1995
4. 4. Kim NW, Piatysek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994
5. 5. Harrington L, McPhail T, Mar V, Zhou W, Arruda I, Robinson MO: A mammalian telomerase-associated protein. Science 275:973-977, 1997
6. 6. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F: TLPI: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88:875-884, 1997
7. 7. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B: The RNA component of human telomerase. Science 269:1236-1241, 1995
8. 8. Blasco MA, Funk W, Villeponteau B, Greider CW: Functional characterization and developmental regulation of mouse telomerase RNA. Science 269:1267-1270, 1995
9. 9. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR: Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276:561-567, 1997
10. 10. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Biejersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795, 1997
11. 11. Greider CW: Telomere length regulation. Annu Rev Biochem 65:337-365, 1996
12. 12. Holt SE, Wright WE, Shay JW: Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16:2932-2939, 1996
13. 13. Kiyozuka Y, Asai A, Senzaki H, Uemura Y, Nakashima A, Morimoto J, Matsuzawa A, Tsubura A: Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression. Int J Mol Med 2:437-444, 1998
14. 14. Sallinen P, Miettinen H, Sallinen SL, Haapasalo H, Helin H, Kononen J: Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 150:1159-1164, 1997
15. 15. Zhang W, Piatyszek A, Kobayashi T, Estey E, Andreeff M, Deisseroth AB, Wright WE, Shay JW: Telomerase activity in human acute myelogeneous leukemia: Inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 2:799-803, 1996
16. 16. Asai A, Kiyozuka Y, Yoshida R, Fujii T, Hioki K, Tsubura A: Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: Correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs. Anticancer Res 18:1465-1472, 1998
17. 17. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK and Schnaper W: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in murine model. Circulation 91:755-762, 1995
18. 18. Li SD, Wang XQ: Observation of effects of cAMP plus theophylline on human esophageal cancer cell line (E17). Chung Hua Chung Liu Tsa Chih 1:20-22, 1979
19. 19. Rabin H, Gonda A, Benton CV, Robinson KM: Cell culture studies of simian and human esophageal carcinoma. In Cancer of the Esophagus, Vol 2. C Pfeiffer (eds). Boca Raton, Florida, CRC Press, 1982, pp 99-111
20. 20. Hu CP, Hsieh HG, Chien KY, Wang PY, Wang CI, Chen CY, Lo SJ, Wuu KD, Chang CM: Biologic properties of three newly established human esophageal carcinoma cell lines. J Natl Cancer Inst 72:577-583, 1984
21. 21. Nishihara T, Kasai M, Kitamura M, Hirayama K, Akaishi T, Sekine Y: Biological characteristics of human esophageal carcinomas and tumors transplantable to nude mice originating from human esophageal carcinomas and their clinical application. In: In Vitro Models for Cancer Research, Vol. 1. M Webber, L Sekely (eds). Boca Raton, Florida, CRC Press, 1985, pp 65-79
22. 22. Banks-Schlegel SP, Quintero J: Growth and differentiation of human esophageal carcinoma cell lines. Cancer Res 46:250-258, 1986
23. 23. Li XT, Lin C, Li PY: Comparison of in vitro assays for the cytotoxic effect of anticancer drugs. Chung Hua Chung Liu Tsa Chin 8:184-186, 1986
24. 24. Matsuoka H, Sugimachi K, Ueno H, Kuwano H, Nakano S, Nakayama M: Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Res 47:4134-4140, 1987
25. 25. Sato K, kasono K, Ohba Y, Yashiro T, Fujii Y, Yoshida MA, Tsushima T, Shizume K: Establishment of a parathyroid hormone-like factor-producing esophageal carcinoma cell line (EC-GI). Jpn J Caner Res 78:1044-1048, 1987
26. 26. Su YA: Evolution of human esophageal cancer cell in the process of cell line establishment. Chung Hua Chung Liu Tsa Chin 10:410-413, 1988
27. 27. Pan QQ: Studies on esophageal cancer cells in vitro. Proc Chin Acad Med Sci Peking Union Med Coll 4:52-57, 1989
28. 28. Trujillo JM, Yang LY: Synergism of 1-beta-D-arabinofurano-sylcytosine and cis-diaminedichloroplatinumin - their lethal efficacies against seven established cancer cell lines of gastrointestinal origin. Anticancer Res 9:197-201, 1989
29. 29. Nakamura M: Establishment and characterization of a new human esophageal cancer cell line (YES-1). Nippon Geka Hokan 60:3-12, 1991
30. 30. Utsumi Y, Nakamura T, Nagasue N, Kubota H, Harada T, Morikawa S: Effect of 17 beta-estradiol on the growth of an estrogen receptor-positive human esophageal carcinoma cell line. Cancer 67:2284-2289, 1991
31. 31. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T: Characterization of 21 newly established esophageal cancer cell lines. Cancer 69:277-284, 1992
32. 32. Saito T, Hikita M, Kohno K, Tanimura H, Miyahara M, Kobayashi M: Enhanced expression of the multidrug resistance gene in vindesine-resistant human esophageal cancer cells. Oncology 51:440-445, 1994
33. 33. Saito T, Kato H, Saito M, Karaki Y, Tazawa K, Fujimaki M: TNF receptor number-dependent cytotoxicity to TNF-resistant human esophageal cancer cell lines by combination with recombinant human necrosis factor and hyperthermia. Hum Cell 7:55-61, 1994
34. 34. Tanaka T, Yamana H, Fujita H, Ono T, Tou Y, Fujii T, Uhi T, Shirouzu K: An experimental study on antitumor effect of MMC-fibrin glue micture. Gan To Kagaku Ryoho 23:1400-1402, 1996
35. 35. Shin R, Naomoto Y, Kamikawa Y, Tanaka N, Orita K: Effect of suramin on human esophageal cancer cells in vitro and in vivo. Scand J Gastroenterol 32:824-828, 1997
36. 36. Bryan TM, Reddel RR: Telomere dynamics and telomerase activity in in vitro immortalized human cells. Eur J Cancer 33:767-773, 1997
37. 37. Walmsley RM, Petes TD: Genetic control of chromosome length in yeast. Proc Natl Acad Sci USA 82:506-510, 1985
38. 38. Wright WE, Shay JW: Telomere positional effect and the regulation of cellular senescence. Trends Genet 8:193-197, 1992
39. 39. Harley CB: Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 256:271-282, 1991
40. 40. Boultwood J, Fidler C, Kusec R, Rack K, Elliott PJ, Atoyebi O, Chapman R, Oseier DG, Wainscoat JS: Telomere length in myelodysplastic syndromes. Am J Hematol 56:266-271, 1997
41. 41. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, Tahara E, Shay JW, Barrett JC, Oshimura M: Jpn J Cancer Res 86:899-904, 1995
42. 42. Sallinen P, Miettinen H, Sallinen S-L, Haapasalo H, Helin H, Kononen J: Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 150:1159-1164, 1997
43. 43. Kim NW: Clinical implications of telomerase in cancer. Eur J Cancer 33:781-786, 1997
44. 44. Takahashi H, Shikata N, Senzaki H, Shintaku M, Tsubura A: Immunohistochemical staining patterns of keratins in normal oesophageal epithelium and carcinoma of the oesophagus. Histopathology 26:45-50, 1995